Package | us.nlm.vsac |
Type | ValueSet |
Id | Id |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.117.1.7.1.226/expansion |
Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.226 |
Version | 20210220 |
Status | active |
Date | 2021-02-20T01:02:00-05:00 |
Name | ThrombolyticTPATherapy |
Title | Thrombolytic tPA Therapy |
Experimental | False |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for medications prescribed for thrombolytic (t-PA) therapy for treatment of ischemic stroke.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that representĀ a medication for stroke treatment consistent with administration by intravenous (IV) route.),(Exclusion Criteria: No exclusions.) |
No resources found
CodeSystem | |
http://www.nlm.nih.gov/research/umls/rxnorm ![]() | RxNorm |
http://www.nlm.nih.gov/research/umls/rxnorm ![]() | RxNorm |
{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113883.3.117.1.7.1.226",
"meta" : {
"versionId" : "31",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "TJC EH Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-keyWord",
"valueString" : "STK-05"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-01-19"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2021-02-20"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.226",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.3.117.1.7.1.226"
}
],
"version" : "20210220",
"name" : "ThrombolyticTPATherapy",
"title" : "Thrombolytic tPA Therapy",
"status" : "active",
"experimental" : false,
"date" : "2021-02-20T01:02:00-05:00",
"publisher" : "TJC EH Steward",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for medications prescribed for thrombolytic (t-PA) therapy for treatment of ischemic stroke.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for stroke treatment consistent with administration by intravenous (IV) route.),(Exclusion Criteria: No exclusions.)",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept" : [
{
"code" : "1804799",
"display" : "alteplase 100 MG Injection"
},
{
"code" : "1804804",
"display" : "alteplase 50 MG Injection"
},
{
"code" : "313212",
"display" : "tenecteplase 50 MG Injection"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:5e6f3ddf-c860-45c5-92ab-72d57753bc30",
"timestamp" : "2024-12-10T10:01:51-05:00",
"total" : 3,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1804799",
"display" : "alteplase 100 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1804804",
"display" : "alteplase 50 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "313212",
"display" : "tenecteplase 50 MG Injection"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.